ArticlePulmonary circulation

Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors.

Robert P Frantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.